Merck & Company Inc (MRK BE) stock market data APIs
€113.4194
-1.47(-1.3%)
as of August 15, 2025
Try our APIs with
free plan!
Merck & Company Inc Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for MRK.BE.
Prev. Close
113.4194
Open
111.9519
High
111.6506
Low
111.9519
52 wk Range
104.85-172.2267
Market Cap
97 608 M
Dividends (Yield)
0.0134
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Merck & Company Inc data using free add-ons & libraries
Get Merck & Company Inc Fundamental Data
Merck & Company Inc Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-08-07
- EPS/Forecast: 2.14
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Merck & Company Inc News
New
Environmental Testing Products Company Evaluation Report 2025 | Agilent Technologies, Merck KGaA, and PerkinElmer Lead with Advanced Analytical and Life Science Solutions
Company Logo The Environmental Testing Companies Quadrant by MarketsandMarkets 360 offers an in-depth analysis of the global environmental testing market, highlighting over 120 evaluated companies wi...
Peptide Synthesis Company Evaluation Report 2025 | Thermo Fisher Scientific, Merck KGaA, and Agilent Technologies Lead with Advanced Instruments, Reagents, and Strategic Expansions
Company Logo The Peptide Synthesis Market Companies Quadrant provides in-depth analysis of the global peptide synthesis industry, spotlighting key players, technological strides, product innovations,...
Merck KGaA's (ETR:MRK) Earnings Seem To Be Promising
Merck KGaA's (ETR:MRK) recent earnings report didn't offer any surprises, with the shares unchanged over the last week. We did some analysis to find out why and believe that investors might be missing...
Merck KGaA Second Quarter 2025 Earnings: Misses Expectations
Explore Merck KGaA's Fair Values from the Community and select yours Merck KGaA (ETR:MRK) Second Quarter 2025 Results Key Financial Results Revenue: €5.26b (down 1.8% from 2Q 2024). Net income: �...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
